+3.3 (c = 4.14, CHCl 3 ); IR (neat, cm -1 ) : 3400-3100, 2665, 2931, 2854, 1785, 1750, 1691, 1661, 1496, 1455, 1394, 1374, 1290, 1197, 1174, were sequentially added to a solution of (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoic 5 acid (264 mg, 1 mmol) and n-Bu 4 NHSO 4 (37 mg, 0.1 mmol) in CH 2 Cl 2 (2 mL). The reaction mixture was vigorously stirred at room temperature for 1 h and CH 2 Cl 2 (10 mL) was added.
The organic layer was separated, washed with brine (2  10 mL), dried over anhydrous 
(4E)-5,9-Dimethyldeca-4,8-dienoic Acid [(E)-(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-SBenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyloxy]methyl Ester (3):
A solution of Penicillin G sodium salt (186 mg, 0.5 mmol) and (E)-chloromethyl 5,9-dimethyldeca-4,8-dienoate (125 mg, 0.51 mmol) in dry DMF (4 mL) was stirred at room temperature for 3 days. The reaction mixture was then concentrated in vacuo and the residue was purified by flash column chromatography on silica gel (cyclohexane/AcOEt, 5:1) to afford the title compound as a yellow oil (160 mg, 59% -3200, 2960-2920, 1790, 1764, 1689, 1659, 1496, 1455, 1374, 1292, 1240, 1199, 1158, 1131, 1117, 987, 973 After 2h of incubation at 37°C, 5% CO 2 , cells were washed 3-times with PBS and the coverslips were incubated with 3% PFA-PBS for 15 min at room temperature. Cells were 
